IMPROVING THE APPROPRIATE PRESCRIBING OF PROTON PUMP INHIBITORS (PPI) AMONG REFERRED PATIENTS IN HEALTHCARE CLINICS UNDER THE HEALTH OFFICE OF KLANG DISTRICT

Authors

  • Lean Ean Pheng Author
  • Nur Syellawaty Ahmad Author
  • Che Ping Wun Author
  • Izan Hairani Ishak Author
  • Tamilselvi Antony Author
  • Tan Zhu Yun Author

DOI:

https://doi.org/10.63719/qbulletin.v1i31.292

Keywords:

Proton pump inhibitor, Primary care, Appropriate use, Quality improvement study

Abstract

Proton pump inhibitors (PPIs) are prescribed for acid-related gastrointestinal disorders. However, inappropriate prescribing of PPIs may cause serious side effects, such as community-acquired pneumonia, bone fracture and Clostridium difficile infection. Additionally, it results in unnecessary healthcare costs. This study aimed to improve the appropriateness of PPI prescriptions to at least 66% within a four-month intervention period. A quality improvement study was conducted in 12 health clinics with resident pharmacists under the Health Office of Klang District (HOKD) in March 2018. All prescriptions of PPIs were assessed except for Sistem Pendispensan Ubat Bersepadu (SPUB) prescriptions from external facilities. A pre-interventional data review of 284 PPI prescriptions received in March 2018 showed that only 1.76% (n=5) was deemed appropriate. The contributing factors identified included lack of interventions by clinicians and pharmacists, incomplete indications of PPIs on prescriptions, insufficient PPI information on discharge letters and lack of assessment guidelines. In this study, the pharmacist review form (PRF) on PPIs was designed as the intervention tool for the screening process; PPI educational training sessions were conducted for clinicians and pharmacists; counselling checklists and patient education leaflets were developed to improve the effectiveness of the counselling sessions; and algorithm of PPI deprescribing was developed for practice by clinicians. Moreover, project findings were shared with Tengku Ampuan Rahimah Hospital to increase awareness of issues related to incomplete documentation of PPI prescriptions in discharge summaries and referral letters. In July 2018, the percentage of appropriate PPI prescriptions had increased from 1.8% (n=5/284) to 69.8% (n=487/698), and subsequently to 91.9% (n=124/135) by 28th February 2019. In conclusion, continuous intervention implementation and regular monitoring of outcomes prevent potential PPI side effects and unnecessary healthcare costs.

Author Biographies

  • Lean Ean Pheng

    Klang District Health Office, Selangor State Health Department, Ministry of Health Malaysia

  • Nur Syellawaty Ahmad

    Klang District Health Office, Selangor State Health Department, Ministry of Health Malaysia

  • Che Ping Wun

    Tengku Ampuan Rahimah Hospital, Selangor State Health Department, Ministry of Health Malaysia

  • Izan Hairani Ishak

    Klang District Health Office, Selangor State Health Department, Ministry of Health Malaysia

  • Tamilselvi Antony

    Klang District Health Office, Selangor State Health Department, Ministry of Health Malaysia

  • Tan Zhu Yun

    Klang District Health Office, Selangor State Health Department, Ministry of Health Malaysia

References

1. Ministry of Health. Formulari Ubat Kementerian Kesihatan 2021 Malaysia. Pharmaceutical Services Division Ministry of Health Malaysia. 2021;1.

2. Murie J, Allen J, Simmonds R, De Wet C. Glad you brought it up: A patient centred programme to reduce proton-pump inhibitor prescribing in general medical practice. Qual Prim Care. 2012;20(2):141–8.

3. Sattayalertyanyong O, Thitilertdecha P, Auesomwang C. The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study. Int J Clin Pharm [Internet]. 2020;42(1):174–83. Available from: https://doi.org/10.1007/s11096-019-00955-8

4. Rotman SR, Bishop TF. Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002-2009. PLoS One. 2013;8(2):2002–9.

5. Akram F, Huang Y, Lim V, Huggan PJ, Merchant RA. Proton pump inhibitors: Are we still prescribing them without valid indications? Australia’s Med J. 2014;7(11):465–70.

6. Akkawi ME, Elnaem MH. Evaluation of the prescribing of proton pump inhibitors as stress ulcer prophylaxis for non-ICU patients in a Malaysian tertiary hospital. Drugs Ther Perspect [Internet]. 2020;36(11):529–34. Available from: https://doi.org/10.1007/s40267-020-00770-6

7. Fah TR, Jun TY, Yan P, Jinyu C. Appropriateness of Proton Pump Inhibitors Prescription In Patients Admitted To A Malaysian Tertiary Hospital. Int J public Heal Res. 2019;9(1):1043–50.

8. Giannini EG, Crespi M, Djahandideh A, Demarzo MG, Moscatelli A, Bodini G, et al. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation. Dig Liver Dis [Internet]. 2020;52(8):862–8. Available from: https://doi.org/10.1016/j.dld.2020.05.005

9. Savarino V, Dulbecco P, de Bortoli N, Ottonello A, Savarino E. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal. Eur J Intern Med [Internet]. 2017;37:19–24. Available from: http://dx.doi.org/10.1016/j.ejim.2016.10.007

10. Bundeff AW, Zaiken K. Impact of clinical pharmacists’ recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice. J Manag Care Pharm. 2013;19(4):325–33.

11. Nallapeta N, Reynolds JL, Bakhai S. Deprescribing proton pump inhibitors in an academic, primary care clinic: Quality improvement project. J Clin Gastroenterol. 2020;54(10):864–70.

12. Dylan R, Erin G, Jaime RH. Appropriate Use and Stewardship of Proton-Pump Inhibitors. US Pharm. 2019;44(12):25–31.

13. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, et al. Proton pump inhibitors linked to hypomagnesemia: A systematic review and meta-analysis of observational studies. Ren Fail. 2015;37(7):1237–41.

14. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of clostridium difficile infection with acid suppressing drugs and antibiotics: Meta analysis. Am J Gastroenterol [Internet]. 2012;107(7):1011–9. Available from: http://dx.doi.org/10.1038/ajg.2012.108

15. Eom CS, Park SM, Myung SK, Yun JM, Ahn JS. Use of acid-suppressive drugs and risk of fracture: A meta-analysis of observational studies. Ann Fam Med. 2011;9(3):257–67.

16. Ahrens D, Behrens G, Himmel W, Kochen MM, Chenot JF. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int J Clin Pract. 2012;66(8):767–73.

17. Roza MA De, Kam JW, Kai L, Chan YH. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis. World J Gastroenterol. 2019;25(33):4933–44.

18. Ahrens D, Chenot JF, Behrens G, Grimmsmann T, Kochen MM. Appropriateness of treatment recommendations for PPI in hospital discharge letters. Eur J Clin Pharmacol. 2010;66(12):1265–71.

19. Rosaida MS, Menon J, Radzi H, Yung CL, P MTH, Yip KF, et al. Use of Drugs for Acid Related Disorders. Malaysian Statistics On Medicines 2007;1–4.

20. Ministry of Health. National Survey on the Use of Medicines (NSUM) By Malaysian Consumers. Pharmaceutical Services Division Ministry of Health Malaysia. 2016.

21. Lodato F, Poluzzi E, Raschi E, Piccinni C, Koci A, Olivelli V, et al. Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy. Eur J Intern Med [Internet]. 2016;30:31–6. Available from: http://dx.doi.org/10.1016/j.ejim.2016.01.025

22. Jawatankuasa Farmasi Ambulatori, Bahagian Amalan Dan Perkembangan Farmasi, Malaysia. Garispanduan Sistem Pendispensan Ubat Bersepadu, 2021.

23. Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, Rojas-Fernandez C, Walsh K, Welch V, Moayyedi P. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline. Can Fam Physician. 2017;63(5):354-364.

24. Ministry of Health. Bahagian Pembangunan Kesihatan Keluarga, Malaysia: Klasifikasi Klinik Kesihatan, 2019.

Downloads

Published

31-10-2022

Issue

Section

Articles

How to Cite

1.
IMPROVING THE APPROPRIATE PRESCRIBING OF PROTON PUMP INHIBITORS (PPI) AMONG REFERRED PATIENTS IN HEALTHCARE CLINICS UNDER THE HEALTH OFFICE OF KLANG DISTRICT. Q Bulletin [Internet]. 2022 Oct. 31 [cited 2026 Nov. 23];1(31). Available from: https://journal.nih.gov.my/index.php/qbulletin/article/view/292

Most read articles by the same author(s)

Similar Articles

1-10 of 42

You may also start an advanced similarity search for this article.